Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient?
The objective of the presentation will be to answer , based on some evidences,referred to the eventual additive contributions of the three tests with Progession to Diabetes (PDMT2) and/or exposure to Cardiovascular Risk (CVR) or Chronic Renal Disease (CRD) and how we can use them from a clinical per...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2022-09-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://revistasad.com/index.php/diabetes/article/view/553 |
| _version_ | 1797983991411769344 |
|---|---|
| author | Isaac Sinay |
| author_facet | Isaac Sinay |
| author_sort | Isaac Sinay |
| collection | DOAJ |
| description | The objective of the presentation will be to answer , based on some evidences,referred to the eventual additive contributions of the three tests with Progession to Diabetes (PDMT2) and/or exposure to Cardiovascular Risk (CVR) or Chronic Renal Disease (CRD) and how we can use them from a clinical perspective.
In prediabetes definition there are no discrepancias regarding to Impaired Glucose Tolerance (IGT), but they are obvious regarding Impaired Fasting Glucose (IFG) = American Diabetes Association criteria : 100-125 mg/dl an World Health Organization : 110-125 mg/dl. There no agreement also for “intermediate” HbA1c cutoffs = (HbA1c(5.7-6.4%)) for American Diabetes Association and (HbA1c(6.1-6.4%)) in UK (NICE). These divergences have different risk of progression and also the pathophysiological contributions of each of the evaluations could be complementary. |
| first_indexed | 2024-04-11T06:54:47Z |
| format | Article |
| id | doaj.art-988c76703c8e42139b14cfc48c920b47 |
| institution | Directory Open Access Journal |
| issn | 0325-5247 2346-9420 |
| language | Spanish |
| last_indexed | 2024-04-11T06:54:47Z |
| publishDate | 2022-09-01 |
| publisher | Sello Editorial Lugones |
| record_format | Article |
| series | Revista de la Sociedad Argentina de Diabetes |
| spelling | doaj.art-988c76703c8e42139b14cfc48c920b472022-12-22T04:39:03ZspaSello Editorial LugonesRevista de la Sociedad Argentina de Diabetes0325-52472346-94202022-09-01563Sup111110.47196/diab.v56i3Sup.553467Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient?Isaac Sinay0Instituto Cardiovascular de Buenos Aires, Ciudad Autónoma de Buenos Aires, ArgentinaThe objective of the presentation will be to answer , based on some evidences,referred to the eventual additive contributions of the three tests with Progession to Diabetes (PDMT2) and/or exposure to Cardiovascular Risk (CVR) or Chronic Renal Disease (CRD) and how we can use them from a clinical perspective. In prediabetes definition there are no discrepancias regarding to Impaired Glucose Tolerance (IGT), but they are obvious regarding Impaired Fasting Glucose (IFG) = American Diabetes Association criteria : 100-125 mg/dl an World Health Organization : 110-125 mg/dl. There no agreement also for “intermediate” HbA1c cutoffs = (HbA1c(5.7-6.4%)) for American Diabetes Association and (HbA1c(6.1-6.4%)) in UK (NICE). These divergences have different risk of progression and also the pathophysiological contributions of each of the evaluations could be complementary.https://revistasad.com/index.php/diabetes/article/view/553diabetes mellitus |
| spellingShingle | Isaac Sinay Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? Revista de la Sociedad Argentina de Diabetes diabetes mellitus |
| title | Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? |
| title_full | Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? |
| title_fullStr | Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? |
| title_full_unstemmed | Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? |
| title_short | Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient? |
| title_sort | symposium 3 fasting plasma glucose hba1c or oral glucose tolerance test should we use the three tests to evaluate the patient |
| topic | diabetes mellitus |
| url | https://revistasad.com/index.php/diabetes/article/view/553 |
| work_keys_str_mv | AT isaacsinay symposium3fastingplasmaglucosehba1cororalglucosetolerancetestshouldweusethethreeteststoevaluatethepatient |